120 related articles for article (PubMed ID: 30789393)
1. 18F FDG Uptake Due to Late-Onset Osteoradionecrosis for Tongue Base Carcinoma.
Dholam KP; Singh GP; Agarwal JP; Mahajan A
Clin Nucl Med; 2019 May; 44(5):e345-e346. PubMed ID: 30789393
[TBL] [Abstract][Full Text] [Related]
2. Risk assessment of osteoradionecrosis associated with periodontitis using
Ito K; Takumi K; Meibom SK; Qureshi MM; Fujima N; Andreu-Arasa VC; Truong MT; Salama AR; Kaneda T; Sakai O
Eur J Radiol; 2020 Nov; 132():109259. PubMed ID: 33012550
[TBL] [Abstract][Full Text] [Related]
3. Squamous cell carcinoma of the tongue with cardiac metastasis on 18F-FDG PET/CT: A case report and literature review.
Delabie P; Evrard D; Zouhry I; Ou P; Rouzet F; Benali K; Piekarski E
Medicine (Baltimore); 2021 Apr; 100(15):e25529. PubMed ID: 33847677
[TBL] [Abstract][Full Text] [Related]
4. Utility of TL-201 SPECT in clarifying false-positive FDG-PET findings due to osteoradionecrosis in head and neck cancer.
Wang CH; Liang JA; Ding HJ; Yang SN; Yen KY; Sun SS; Kao CH
Head Neck; 2010 Dec; 32(12):1648-54. PubMed ID: 20848403
[TBL] [Abstract][Full Text] [Related]
5. False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient.
Liu SH; Chang JT; Ng SH; Chan SC; Yen TC
Br J Radiol; 2004 Mar; 77(915):257-60. PubMed ID: 15020372
[TBL] [Abstract][Full Text] [Related]
6. Detection of cancer recurrence in irradiated mandible using positron emission tomography.
Minn H; Aitasalo K; Happonen RP
Eur Arch Otorhinolaryngol; 1993; 250(5):312-5. PubMed ID: 8217137
[TBL] [Abstract][Full Text] [Related]
7. Osteoradionecrosis after three-dimensional conformal radiotherapy for recurrent cervical cancer presenting as a progressive osteolytic lesion.
Lee JA; Huh SJ; Oh D; Bae DS
Ann Nucl Med; 2008 Feb; 22(2):139-41. PubMed ID: 18311539
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT in Osteoradionecrosis of the Hyoid.
Antippa SH; Du L; Price N; Hsu CC
Clin Nucl Med; 2021 Jan; 46(1):e49-e50. PubMed ID: 32956123
[TBL] [Abstract][Full Text] [Related]
9. FDG PET/CT in Carcinoma of the Tongue With Bilateral Adrenal Metastases.
Agarwal KK; Parida GK; Tripathi M; Sahoo MK; Thakar A; Bal CS; Kumar R
Clin Nucl Med; 2017 Feb; 42(2):123-124. PubMed ID: 27997430
[TBL] [Abstract][Full Text] [Related]
10. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma.
Li XF; Fu Q; Dong YW; Liu JJ; Song XY; Dai D; Zuo C; Xu WG
World J Gastroenterol; 2016 Sep; 22(34):7787-96. PubMed ID: 27678362
[TBL] [Abstract][Full Text] [Related]
11. Differentiating osteoradionecrosis from nasopharyngeal carcinoma tumour recurrence using ⁹⁹Tcm-sestamibi SPECT/CT.
Tan AE; Ng DC
Br J Radiol; 2011 Sep; 84(1005):e172-5. PubMed ID: 21849357
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT in Metastatic Pilomatrix Carcinoma.
Vadrucci M; Gilardi L; Crivelli F; Baroli A; Lomuscio G
Clin Nucl Med; 2016 Dec; 41(12):e525-e526. PubMed ID: 27824328
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary FDG uptake without a CT counterpart - a pitfall in interpreting PET/CT images.
Schreiter N; Nogami M; Buchert R; Froeling V; Brenner W; Diekmann F
Acta Radiol; 2011 Jun; 52(5):513-5. PubMed ID: 21498287
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
Alongi P; Evangelista L; Caobelli F; Spallino M; Gianolli L; Midiri M; Picchio M
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
[TBL] [Abstract][Full Text] [Related]
15. Extraordinarily high F-18 FDG uptake caused by radiation necrosis in a patient with nasopharyngeal carcinoma.
Hung GU; Tsai SC; Lin WY
Clin Nucl Med; 2005 Aug; 30(8):558-9. PubMed ID: 16024955
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of volumetric FDG PET/CT parameters in patients with oral tongue squamous cell carcinoma who were treated by superselective intra-arterial chemoradiotherapy.
Suzuki-Shibata S; Yamamoto Y; Yoshida T; Mizoguchi N; Nonaka T; Kubota A; Narimatsu H; Miyagi Y; Kobayashi T; Kaneta T; Inoue T
Jpn J Radiol; 2017 Dec; 35(12):740-747. PubMed ID: 29039110
[TBL] [Abstract][Full Text] [Related]
17. The intensity of 18FDG uptake does not predict tumor growth in patients with metastatic differentiated thyroid cancer.
Terroir M; Borget I; Bidault F; Ricard M; Deschamps F; Hartl D; Tselikas L; Dercle L; Lumbroso J; Baudin E; Berdelou A; Deandreis D; Schlumberger M; Leboulleux S
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):638-646. PubMed ID: 27796544
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging
Okuyucu K; Ince S; Alagoz E; Emer O; San H; Balkan E; Ayan A; Meric C; Haymana C; Acıkel C; Gunalp B; Karacalioglu AO; Arslan N
Hell J Nucl Med; 2016; 19(3):208-217. PubMed ID: 27824959
[TBL] [Abstract][Full Text] [Related]
19. 18F-fluorodeoxyglucose-positive Warthin tumor in a contralateral cervical lymph node mimicking metastasis in tongue cancer staging with PET/CT.
Iwai T; Baba J; Shibasaki M; Omura S; Hirota M; Mitsudo K; Tohnai I
J Craniofac Surg; 2012 Sep; 23(5):e507-9. PubMed ID: 22976724
[TBL] [Abstract][Full Text] [Related]
20. Fluorodeoxyglucose activity associated with a cosmetic poly-L-lactide filler: a potential confounder on positron emission tomography and computed tomography.
Dwivedi K; Prabhu IS; Bradley KM
Br J Oral Maxillofac Surg; 2018 Feb; 56(2):148-150. PubMed ID: 29290390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
